Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

SIRT1 (human), (recombinant) (His-tag)

Highly active
BML-SE239-0100 100 U 361.00 USD
Do you need bulk/larger quantities?

Product Specification

Alternative Name:Sirtuin 1
MW:82 kDa
Source:Produced in E. coli. Recombinant SIRT1 from human cDNA containing an N-terminal His-tag.
UniProt ID:Q96EB6
Gene/Protein Identifier:NM_012238 (RefSeq)
Formulation:Liquid. In 25 mM TRIS, pH 7.5, 100mM NaCl, 5mM DTT and 10% glycerol.
Purity Detail:Partially purified by single-step affinity chromatography and gel filtration.
Specific Activity:One unit = 1pmol/min at 37°C, 250µM FLUOR DE LYS® substrate (Prod. No. BML-KI104), 500µM NAD+.
Shipping:Shipped on Dry Ice
Long Term Storage:-80°C
Regulatory Status:RUO - Research Use Only

Product Literature References

Identification of Diketopiperazine-Containing 2-Anilinobenzamides as Potent Sirtuin 2 (SIRT2)-Selective Inhibitors Targeting the "Selectivity Pocket", Substrate-Binding Site, and NAD+-Binding Site: P. Mellini, et al.; J. Med. Chem. 62, 5844 (2019), Abstract;
Pharmacophore modeling and virtual screening studies to identify novel selective SIRT2 inhibitors: G. Eren, et al.; J. Mol. Graph. Model. 10, 1313 (2019), Abstract;
Two Novel Proline-Containing Catechin Glucoside from Water-Soluble Extract of Codonopsis pilosula: F.Y. Qin, et al.; Molecules 23, E180 (2018), Application(s):SIRT1 Inhibition, Abstract; Full Text
Design, synthesis and structure-activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton: T. Sakai, et al.; Bioorg. Med. Chem. 23, 328 (2015), Abstract;
Discovery of bicyclic pyrazoles as class III histone deacetylase SIRT1 and SIRT2 inhibitors: E. Therrien, et al.; Bioorg. Med. Chem. Lett. 25, 2514 (2015), Abstract;
Functionalized tetrahydro-1H-pyrido[4,3-b]indoles: a novel chemotype with Sirtuin 2 inhibitory activity: T. Yang, et al.; Eur. J. Med. Chem. 92, 145 (2015), Abstract;
AROS has a context-dependent effect on SIRT1: T. Kokkola, et al.; FEBS Lett. 588, 1523 (2014), Application(s): In vitro activity assay, Abstract;
Cytotoxicity and cell death mechanisms induced by a novel bisnaphthalimidopropyl derivative against the NCI-H460 non-small lung cancer cell line: R.T. Lima, et al.; Anticancer Agents Med. Chem. 13, 414 (2013), Abstract;
Redox Factor-1 Activates Endothelial SIRTUIN1 through Reduction of Conserved Cysteine Sulfhydryls in Its Deacetylase Domain: S.B. Jung, et al.; PLoS One 8, e65415 (2013), Abstract; Full Text
Regulation of inositol 1,3,4-trisphosphate 5/6-kinase (ITPK1) by reversible lysine acetylation: C. Zhang, et al.; Proc. Natl. Acad. Sci U.S.A. 109, 2290 (2012), Abstract; Full Text
Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated protein kinase: V. Nin, et al.; J. Biol. Chem. 287, 23489 (2012), Abstract; Full Text
A brain-permeable small molecule reduces neuronal cholesterol by inhibiting activity of sirtuin 2 deacetylase: D.M. Taylor, et al.; ACS Chem. Biol. 6, 540 (2011), Abstract;
Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis: M.M. Mihaylova, et al.; Cell 145, 607 (2011), Abstract; Full Text
Electrophoretically mediated microanalysis assay for sirtuin enzymes: Y. Fan, et al.; Electrophoresis 23, 3874 (2010), Abstract;
SIRT1 is a redox-sensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress: S. Caito, et al.; FASEB J. 24, 3145 (2010), Application(s): Mass spectrometry analysis of SIRT1 modified by reactive aldehydes, Abstract; Full Text

Related Products

FLUOR DE LYS® deacetylase substrate 

Highly sensitive and convenient alternative to radiolabeled, acetylated histones or peptide/HPLC methods for the assay of histone deacetylases.
≥95% (HPLC) | Print as PDF
BML-KI104-0050 50 µl 175.00 USD
Do you need bulk/larger quantities?

Related Literature

Stem Cells
Stem Cells
Download as PDF

Download as PDF

All new literature pieces

Recommend this page

Keep in touch

©2020 Enzo Life Sciences, Inc.,